FeesSafety
Pluang+

Braemar Hotels refinances $60M loan for Ritz-Carlton Lake Tahoe, extending debt maturity to 2028.

Company Fundamentals
03 Nov 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
Braemar Hotels refinances $60M loan for Ritz-Carlton Lake Tahoe, extending debt maturity to 2028.

Braemar Hotels & Resorts Inc. has refinanced its mortgage loan for the Ritz-Carlton Lake Tahoe, increasing the loan to $60 million with an additional $15 million available. The new loan has a lower floating interest rate of SOFR + 2.65% and a three-year initial term with options to extend, pushing the next major debt maturity to December 2028. This refinancing improves the company's financial flexibility and takes advantage of tighter interest rate spreads. The move secures funding for one of Braemar's key luxury assets and delays upcoming debt obligations.

Braemar Hotels & Resorts refinancing news is provided here with related market data for context. For readers following Real Estate stocks, 20 out of 47 priced US stocks rose and 24 fell today on Pluang. Notable movers include BRX at USD 29.80 (+0.81%), VMRK at USD 62.70 (+0.77%), and AHR at USD 53.42 (-0.69%). This data is as of Nov 03, 2026 18:41 WIB.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App